• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.

作者信息

Seeldrayers P, Messina D, Desmedt D, Dalesio O, Hildebrand J

出版信息

Acta Neurol Scand. 1985 May;71(5):411-4. doi: 10.1111/j.1600-0404.1985.tb03222.x.

DOI:10.1111/j.1600-0404.1985.tb03222.x
PMID:2409733
Abstract

The cerebrospinal fluid level of homovanilic acid (HVA), 5 hydroxyindolacetic acid (5HIAA) and 3 methoxy-4-hydroxy phenylglycol (MHPG) was determined twice at 12 to 15-day intervals in 23 patients with Alzheimer-type dementia (ATD). No correlation was found with the degree of dementia as assessed by psychometric testing. In most of the patients, the CSF levels of 5HIAA, MHPG and to a lesser extent HVA were found to be rather stable within a period of 2 weeks. The observation of a decrease in the concentration of HVA but not of 5HIAA or MHPG in 10 out of 12 patients treated with ergoloid mesylate may therefore be of interest in elucidating the mechanism of action of this drug in ATD.

摘要

相似文献

1
CSF levels of neurotransmitters in Alzheimer-type dementia. Effects of ergoloid mesylate.
Acta Neurol Scand. 1985 May;71(5):411-4. doi: 10.1111/j.1600-0404.1985.tb03222.x.
2
Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.人类腰椎脑脊液神经递质代谢物浓度的季节性变化。
Psychiatry Res. 1984 May;12(1):79-87. doi: 10.1016/0165-1781(84)90140-9.
3
Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
Psychiatry Res. 1991 Mar;36(3):243-51. doi: 10.1016/0165-1781(91)90023-i.
4
Monoamine metabolites in cerebrospinal fluid and behavioral ratings in patients with early and late onset of Alzheimer dementia.早发型和晚发型阿尔茨海默病痴呆患者脑脊液中的单胺代谢产物及行为评分
Alzheimer Dis Assoc Disord. 1989 Fall;3(3):148-56. doi: 10.1097/00002093-198903030-00004.
5
Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.经组织学证实的阿尔茨海默病痴呆患者腰椎脑脊液中的单胺代谢物浓度。
J Neurol Neurosurg Psychiatry. 1984 May;47(5):481-4. doi: 10.1136/jnnp.47.5.481.
6
3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.人脑脊液中的3-甲氧基-4-羟基苯乙二醇、5-羟基吲哚乙酸和高香草酸。以3-甲氧基-4-羟基苯乳酸为内标,通过反相高效液相色谱法和库仑检测法进行储存和测定。
J Chromatogr. 1984 Dec 12;336(2):259-69.
7
Higher cerebrospinal fluid MHPG in subjects with dementia of the Alzheimer type. Relationship with cognitive dysfunction.阿尔茨海默型痴呆患者脑脊液中 3-甲氧基-4-羟基苯乙二醇(MHPG)水平较高。与认知功能障碍的关系。
Am J Geriatr Psychiatry. 1998 Spring;6(2):155-61.
8
Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.阿尔茨海默病和多发性梗死性痴呆对治疗的临床及生化反应
Eur Arch Psychiatry Neurol Sci. 1989;239(2):79-86. doi: 10.1007/BF01759579.
9
Reproducibility of monoamine metabolite measurements in human cerebrospinal fluid.人体脑脊液中单胺代谢物测量的可重复性。
Acta Neurol Scand. 1990 May;81(5):427-30. doi: 10.1111/j.1600-0404.1990.tb00989.x.
10
Vasopressin levels in CSF of Alzheimer patients: correlations with monoamine metabolites and neuropsychological test performance.阿尔茨海默病患者脑脊液中加压素水平:与单胺代谢产物及神经心理学测试表现的相关性
Psychoneuroendocrinology. 1989;14(1-2):89-95. doi: 10.1016/0306-4530(89)90057-7.

引用本文的文献

1
A long-term follow-up study of cerebrospinal fluid 5-hydroxyindoleacetic acid in delirium.谵妄患者脑脊液5-羟色胺酸的长期随访研究
Eur Arch Psychiatry Clin Neurosci. 1994;244(3):131-4. doi: 10.1007/BF02191886.
2
Clinical and biochemical responses to therapy in Alzheimer's disease and multi-infarct dementia.阿尔茨海默病和多发性梗死性痴呆对治疗的临床及生化反应
Eur Arch Psychiatry Neurol Sci. 1989;239(2):79-86. doi: 10.1007/BF01759579.